AeroEclipse® II Ban Set

The AeroEclipse® II  Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient’s inspiratory flow.  This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments. This set contains two reusable Aeroeclipse XL Breath Actuated Nebulizers. Each Nebulizer is rated to deliver the optimum dosage for six months before replacing.      Consistent respirable dose Virtually no drug is lost to the environment Protection from second-hand aerosols Minimizes medication waste Efficient treatment times Biofeedback button confirms actuation and inhalation Reduced Length of Stay and Admission Rates through the ER1 Not Made or Manufactured with BPA, Natural Rubber Latex, Phthalates, Lead, or PVC Designed and manufactured in North America Combining the benefits of breath actuation and a superior aerosol particle size, the AeroEclipse® II BAN delivers the industry’s most effective respirable dose. Supported by clinica